Skip to Content
Discovering the causes of cancer and the means of prevention

Clinical Genetics Branch

Saving lives and improving the quality of life for individuals at increased genetic risk of cancer

Clinical Genetics Branch (CGB) investigators study individuals at high genetic risk of cancer in order to improve our understanding of cancer etiology and to advance clinical care. This work is carried out through two major research approaches: familial studies and clinical genetics. Read about some of our contributions to improving public health for these high-risk individuals.  

Research Mission

CGB's research mission is to conduct multidisciplinary research to advance our understanding of the molecular pathogenesis of cancer and to translate this knowledge into effective clinical applications for cancer-prone individuals and families, and for individuals at increased risk of cancer from the general population. Learn about specific CGB research areas.

Clinical Epidemiology Unit

The Clinical Epidemiology Unit (CEU) within CGB conducts etiologic research with potential clinical and public health applications, and leads studies evaluating population-based early detection and cancer prevention strategies.

Fellowships

CGB fellows work with researchers engaged in conducting clinical research studies targeting high-risk families, in pursuing astute clinical observations of unusual cancer occurrences that might provide new clues to cancer etiology, and in applying epidemiologic methods to the study of high-risk individuals. Meet the current CGB fellows and learn about research training opportunities in CGB.

CGB Spotlight

Maria Isabel Achatz, M.D., Ph.D, Tenure-track Investigator

Dr. Achatz, a leading geneticist from Brazil, recently joined CGB to study inherited cancer predisposition syndromes, including Li-Fraumeni syndrome, an inherited disorder that dramatically increases affected individuals’ risk for developing cancer. Learn more about Dr. Maria Isabel Achatz.